Cyclosporin-associated central nervous system toxicity after allogeneic bone marrow transplantation

Transplantation. 1984 Jul;38(1):34-7. doi: 10.1097/00007890-198407000-00009.

Abstract

Five of 64 recipients of HLA-identical sibling marrow allografts who were given cyclosporin (CSP) to minimize graft-versus-host disease posttransplant had a serious neurological illness thought to be due to CSP. Characteristic clinical features included a motor spinal cord syndrome, a cerebellar-like syndrome, and mental confusion. All five recovered when the CSP dose was reduced or the drug was stopped.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / chemically induced
  • Adult
  • Ataxia / chemically induced
  • Bone Marrow Transplantation*
  • Central Nervous System Diseases / chemically induced*
  • Confusion / chemically induced
  • Cyclosporins / therapeutic use
  • Cyclosporins / toxicity*
  • Female
  • Graft vs Host Disease / prevention & control
  • Humans
  • Leukemia, Myeloid / therapy
  • Male
  • Memory Disorders / chemically induced
  • Middle Aged
  • Pyramidal Tracts / drug effects
  • Tremor / chemically induced

Substances

  • Cyclosporins